Overview
Hyfe is a health technology company based in Santa Fe, NM, USA, focusing on AI-powered cough detection, monitoring, and analysis. Their innovative solutions include unobtrusive, clinically validated cough monitoring supported by advanced AI models. Hyfe's technology is utilized worldwide by researchers, pharmaceutical companies, and healthcare providers for continuous cough monitoring through a wearable device and a companion app, coupled with a comprehensive dashboard. The company has an estimated annual revenue of $3.8 million, with 34 employees and an employee growth rate of 3%.
Website: [hyfe.com](https://www.hyfe.com/)
Product Offerings
Hyfe specializes in respiratory care through products that facilitate continuous, privacy-focused cough monitoring. The technology ensures user privacy by analyzing only cough timestamps without recording sounds:
- CoughMonitor Suite: A clinically validated tool featuring wearables and apps, providing real-time actionable insights.
- Cohesive AI System: Deployable on smart devices for scalable detection and tracking, enhancing clinical research and patient management.
- Upcoming Launch: World's first prescription Digital Therapeutic (DTx) for chronic cough in partnership with Kyorin Pharmaceutical.
Financials
- Total Funding: $13 million from 12 investors, including Alumni Ventures and Gaingels.
- Valuation: Estimated at $32 million based on past funding rounds.
- Revenue per Employee: Approximately $112,000.
Leadership Team
- Tamsin Chislett: CEO with expertise in operations and strategy.
- Joe Brew: Co-founder & Chief Data Scientist, specializes in public health.
- Peter Small: Chief Medical Officer, providing clinical medicine insights.
- Iulian Circo: Co-founder & Chief Operating Officer, focuses on strategic leadership.
- Paul Rieger: Co-founder & Chief Product Officer, leads product development.
Collaborations and Research
Hyfe has formed strategic partnerships to enhance its global impact:
- Active in 46 global clinical trials for robust data collection.
- Collaborations with ActiGraph and Sensory Cloud Inc. to integrate digital health tools.
Industry Recognition and Impact
Hyfe's AI technology is lauded for low false positives and high sensitivity, setting benchmarks for respiratory care applications and therapeutic advancements. The company processes 26 billion data points, serving 116.3k users in 161 countries, and supports the detection of 52 million coughs.
Main Competitors
Hyfe operates in a competitive digital health landscape, with key competitors being:
1. Strados Labs: Specializes in smart biosensor-based respiratory monitoring and has FDA clearance for wearable devices.
2. Resmonics: Offers CE-certified acoustic AI medical software for monitoring lung symptoms.
3. NuvoAir: Provides virtual cardiopulmonary care with home monitoring devices for chronic conditions.
4. CureMetrix: Focuses on AI-based medical imaging for enhancing disease detection in women's health.
Competitor Strategies
- Strados Labs: Integrates biosensor tech with machine learning and emphasizes regulatory clearance for innovation.
- Resmonics: Uses privacy-preserving AI for infection prevention and respiratory health monitoring.
- NuvoAir: Offers continuous management tools emphasizing usability and accessibility.
- CureMetrix: Positions in AI-driven medical imaging solutions, especially in women’s health, collaborating with partners like Philips.
Market Position and Opportunities
Hyfe's position in AI health tech is strengthened by its niche focus on cough monitoring. Opportunities for growth include:
- Expanding healthcare provider partnerships.
- Seeking regulatory certifications to boost clinical acceptance.
- Global market expansion, especially in pollution-affected urban centers, to increase health solution integration.
Hyfe's innovative AI solutions address a critical health monitoring area. Leveraging its technological edge and strategic partnerships will enhance its competitiveness in the health tech industry.
